David G. Hardie
Dundee, SCT DD15EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
AMPK: a master regulator of mitochondrial quality and quantity.
Journal: Trends in cell biology
Published: January 07, 2026
M1-linked ubiquitination by LUBAC regulates AMPK signalling and the response to energetic stress.
Journal: Cell death and differentiation
Published: October 02, 2025
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Journal: Cell reports
Published: July 29, 2025
Editor's Note: AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
Journal: Molecular cancer research : MCR
Published: March 18, 2025
Assays of Different Mechanisms of AMPK Activation, and Use of Cells Expressing Mutant AMPK to Delineate Activation Mechanisms.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 24, 2025
Transient Receptor Potential V Channels Are Essential for Glucose Sensing by Aldolase and AMPK.
Journal: Cell metabolism
Published: January 16, 2025
The pro-drug C13 activates AMPK by two distinct mechanisms.
Journal: The Biochemical journal
Published: August 28, 2024
CDK4 Phosphorylates AMPKα2 to Inhibit Its Activity and Repress Fatty Acid Oxidation.
Journal: Molecular cell
Published: June 01, 2024
AMPK associates with and causes fragmentation of the Golgi by phosphorylating the guanine nucleotide exchange factor GBF1.
Journal: Journal of cell science
Published: April 10, 2024
AMP-activated protein kinase can be allosterically activated by ADP but AMP remains the key activating ligand.
Journal: The Biochemical journal
Published: April 09, 2024
BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation.
BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation.
Journal: International journal of molecular sciences
Published: November 21, 2023
Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancers.
Journal: The Biochemical journal
Published: September 07, 2023
Last Updated: 09/26/2026